Glyxambi
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 4570
  • Home
  • Print this page
  • Email this page
BRIEF COMMUNICATION
Year : 2012  |  Volume : 60  |  Issue : 3  |  Page : 220-223

Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis


1 Gokhale Eye Hospital and Eyebank, Dadar, Mumbai, Maharashtra, India
2 Department of Rheumatology, P.D. Hinduja National Hospital and Medical Research Center, Mahim, Mumbai, Maharashtra, India

Correspondence Address:
Nikhil S Gokhale
Gokhale Eye Hospital and Eyebank, Anant Building, Gokhale Road (S), Dadar West, Mumbai - 400 028, Maharashtra
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/0301-4738.95878

Rights and Permissions

We report the success of oral cyclosporine therapy in a patient with severe vision-threatening vernal keratoconjunctivitis. A child presented with severe allergy which was not controlled with topical steroids, cyclosporine and mast cell stabilizers. Oral steroids were required repeatedly to suppress inflammation. Child showed a dramatic improvement and stabilization with oral cyclosporine therapy. Oral cyclosporine therapy can be tried in severe vision-threatening allergy refractory to conventional therapy.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed5198    
    Printed49    
    Emailed4    
    PDF Downloaded327    
    Comments [Add]    
    Cited by others 3    

Recommend this journal